Eye-Sparing Treatment for Diffuse Invasive Conjunctival Melanoma
We describe a patient with diffuse invasive conjunctival melanoma and lymph node involvement treated by tumor debulking, brachytherapy (custom unshielded radioactive device), and adjuvant ipilimumab who has had a favorable outcome without emergence of local tumor relapse or distant metastasis during 16 months of follow up.Ocul Oncol Pathol 2018;4:261 –266
Source: Ocular Oncology and Pathology - Category: Opthalmology Source Type: research
More News: Brachytherapy | Cancer & Oncology | Melanoma | Opthalmology | Pathology | Skin Cancer | Yervoy